These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 11218826

  • 21. Multiple emulsions containing rifampicin.
    Khopade AJ, Jain NK.
    Pharmazie; 1999 Dec; 54(12):915-9. PubMed ID: 10631755
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M, Sammour OA, Hammad MA, Megrab NA.
    Int J Pharm; 2008 Sep 01; 361(1-2):104-11. PubMed ID: 18577437
    [Abstract] [Full Text] [Related]

  • 25. Niosomes in sustained and targeted drug delivery: some recent advances.
    Azeem A, Anwer MK, Talegaonkar S.
    J Drug Target; 2009 Nov 01; 17(9):671-89. PubMed ID: 19845484
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.
    Hiremath PS, Saha RN.
    Int J Pharm; 2008 Oct 01; 362(1-2):118-25. PubMed ID: 18640251
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
    Aggarwal D, Garg A, Kaur IP.
    J Pharm Pharmacol; 2004 Dec 01; 56(12):1509-17. PubMed ID: 15563757
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs.
    Prabakaran D, Singh P, Jaganathan KS, Vyas SP.
    J Control Release; 2004 Mar 05; 95(2):239-48. PubMed ID: 14980772
    [Abstract] [Full Text] [Related]

  • 39. In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations.
    Panchagnula R, Rungta S, Sancheti P, Agrawal S, Kaul CL.
    Farmaco; 2003 Nov 05; 58(11):1099-103. PubMed ID: 14572860
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.